Inhibition of genotoxic effects of mammalian germ cell mutagens

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 402, Issue 1-2, 1998, Pages 129-138

  Waters, Michael D ^a   Stack, H Frank ^b   Jackson, Marcus A ^b  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b INTEGRATED LABORATORY SYSTEMS   (United States)

Author keywords

Activity profiles; Antimutagens; Bone marrow cytogenetics assays; Germ cells

Indexed keywords

ANIMAL TISSUE; CHEMICAL CARCINOGENESIS; CHROMOSOME ABERRATION; CONFERENCE PAPER; GENOTOXICITY; GERM CELL; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIMUTAGENIC AGENTS; GERM CELLS; MUTAGENS;

EID: 0032543375     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(97)00290-X     Document Type: Conference Paper

References (45)

1. [1] I.L. Adler, J. Ashby, The present lack of evidence for unique rodent germ-cell mutagens, Mutation Res. 212 (1989) 55-66.
2. [2] M.D. Shelby, Selecting chemicals and assays for assessing mammalian germ cell mutagenicity, Mutation Res. 352 (1996) 159-167.
3. [3] M.D. Waters, H.F. Stack, M.A. Jackson, B.A. Bridges, I.-D. Adler, The performance of short-term tests in identifying potential germ cell mutagens: a qualitative and quantitative analysis, Mutation Res. 341 (1994) 109-131.
4. [4] M.D. Waters, A.L. Brady, H.F. Stack, H.E. Brockman, Antimutagenicity profiles for some model compounds, Mutat. Res. 238 (1990) 57-85.
5. [5] R. Balansky, Z. Mircheva, P. Blagoeva, Modulation of the mutagenic activity of cigarette smoke, cigarette smoke condensate and benzo[a]pyrene in vitro and in vivo, Mutagenesis 9 (1994) 107-112.
6. [6] D. Anderson, N. Basaran, S.D. Blowers, A.J. Edwards, The effect of antioxidants on bleomycin treatment in in vitro and in vivo genotoxicity assays, Mutation Res. 329 (1995) 37-47.
7. [7] S. Ghaskadbi, S. Rajmachikar, C. Agate, A.H. Kapadi, V.G. Vaidya, Modulation of cyclophosphamide mutagenicity by vitamin C in the in vivo rodent micronucleus assay, Teratogen. Carcinogen. Mutagen. 12 (1992) 11-17.
8. [8] Y. Odagiri, T. Karube, H. Katayama, K. Takemoto, Modification of the clastogenic activity of X-ray and 6-mercaptopurine in mice by prefeeding with vitamin C and E, J. Nutr. 122 (1992) 1553-1558.
9. [9] M. Lahiri, G.B. Maru, S.V. Bhide, Effect of plant phenols, β-carotene and α-tocopherol on benzo[a]pyrene-induced DNA damage in the mouse forestomach mucosa (target organ) and bone marrow polychromatic erythrocytes (nontarget organ), Mutation Res. 303 (1993) 97-100.
10. [10] A.S. Raj, M. Katz, Beta-carotene as an inhibitor of benzo[a]pyrene and mitomycin C induced chromosomal breaks in the bone marrow of mice, Can. J. Genet. Cytol. 27 (1985) 598-602.
11. [11] H.W. Renner, Anticlastogenic effect of β-carotene in Chinese hamsters - time and dose response studies with different mutagens, Mutation Res. 144 (1985) 251-256.
12. [12] D.M.F. Salvadori, L.R. Ribeiro, M.D.M. Oliveira, C.A.B. Pereira, W. Becak, The protective effect of β-carotene on genotoxicity induced by cyclophosphamide, Mutation Res. 265 (1992) 237-244.
13. [13] A. Mukherjee, K. Agarwal, M.A. Aguilar, A. Sharma, Anticlastogenic activity of β-carotene against cyclophosphamide in mice in vivo, Mutation Res. 263 (1991) 41-46.
14. [14] H.W. Renner, in vivo effects of single or combined dietary antimutagens on mutagen-induced chromosomal aberrations, Mutation Res. 244 (1990) 185-188.
15. [15] K.P. Rao, G. Ramadevi, U.N. Das, Vitamin A can prevent genetic damage induced by benzo(a)pyrene to the bone marrow cells of mice, Int. J. Tissue React. 8 (1986) 219-223.
16. [16] I. Kodytkova, J. Madar, R.J. Sram, Chromosomal aberrations in mouse bone marrow cells and antibody production changes induced by long-term exposure to cyclophosphamide and alpha-tocopherol, Folia Biol. 26 (1980) 94-102.
17. [17] M.Y. Heo, K.S. Yu, K.H. Kim, H.P. Kim, W.W. Au, Anticlastogenic effect of flavonoids against mutagen-induced micronuclei in mice, Mutation Res. 284 (1992) 243-249.
18. [18] Y.F. Sasaki, K. Matsumoto, H. Imanishi, M. Watanabe, T. Ohta, Y. Shirasu, K. Tutikawa, In vivo anticlastogenic and antimutagenic effects of tannic acid in mice, Mutation Res. 244 (1990) 43-47.
19. [19] Y.V. Paschin, L.M. Bakhitova, T.I. Benthen, Increased antimutagenic activity of simple substituted phenols mixed with the hindered phenolic antioxidant dibunol, Food Chem. Toxicol. 24 (1986) 881-883.
20. [20] C.J.M. Rompelberg, W.H. Stenhuis, N. de Vogel, W.A. van Osenbruggen, A. Schouten, H. Verhagen, Antimutagenicity of eugenol in the rodent bone marrow micronucleus test, Mutation Res. 346 (1995) 69-75.
21. [21] T. Inouye, Y.F. Sasaki, H. Imanishi, M. Watanabe, T. Ohta, Y. Shirasu, Suppression of mitomycin C-induced micronuclei in mouse bone marrow cells by post-treatment with vanillin, Mutation Res. 202 (1988) 93-95.
22. [22] S.K. Abraham, L. Sarma, P.C. Kesavan, Role of chlorophyllin as an in vivo anticlastogen: protection against gamma-radiation and chemical clastogens, Mutation Res. 322 (1994) 209-212.
23. [23] A.S. Raj, M. Katz, Glutathione as an inhibitor of chromosomal breakage induced by DMBA, BaP, CP, and MMC assessed by the in vivo bone marrow micronucleus test, Environ. Mutagen. 7 (1985) 52.
24. [24] D. Galdean, D. Petrasincu, P. Alangiu, S. Ibric, N. Voiculetz, The protective effect of thiola against the genotoxic action of benzo[a]pyrene, Experientia 42 (1986) 572-574.
25. [25] P. Rita, D. Geetanjali, P.P. Reddy, Effect of glutathione on mitomycin C-induced micronuclei in bone marrow erythrocytes of Swiss albino mice, Mutation Res. 260 (1991) 131-135.
26. [26] H.W. Renner, The anticlastogenic potential of fatty acid methyl ester, Mutation Res. 172 (1986) 265-269.
27. [27] A.S. Raj, M. Katz, Selenium as an inhibitor of mutagen-induced clastogenicity in mice tested by micronucleus assay, Environ. Mutagen. 8 (1986) 66-67.
28. [28] D.L. Morris, V.M.S. Ramanujam, M.S. Legator, Coumarin inhibits micronuclei formation in male ICR mice by benzo[a]pyrene and alters the pattern of urinary metabolites, in: D.M. Shankel, P.E. Hartman, T. Kada, A. Hollaender (Eds.), Antimutagenesis and Anticarcinogenesi Mechanisms, Plenum, New York, 1986.
29. [29] H.S. Marks, J.L. Anderson, G.S. Stoewsand, Inhibition of benzo[a]pyrene-induced bone marrow micronuclei formation by diallyl thioethers in mice, J. Toxicol. Environ. Health 37 (1992) 1-9.
30. [30] B.L. Harper, M.S. Legator, Pyridine prevents the clastogenicity of benzene but not of benzo[a]pyrene or cyclophosphamide, Mutation Res. 179 (1987) 23-31.
31. [31] A. Korte, R. Slacik-Erben, G. Obe, The influence of ethanol treatment on cytogenetic effects in bone marrow cells of Chinese hamsters by cyclophosphamide, aflatoxin B1 and patulin, Toxicology 12 (1979) 53-61.
32. [32] H.W. Renner, Antimutagenic effect of an antioxidant in mammals, Mutation Res. 135 (1984) 125-129.
33. [33] K. Shimoi, E. Akaiwa, N. Mori, M. Sano, Y. Nakamura, I. Tomita, Bio-antimutagenic activities of vitamin B6 in E. coli and mouse peripheral blood cells, Mutation Res. 266 (1992) 205-213.
34. [34] R.J. Sram, P. Rossner, V.S. Zhurkov, I. Kodytkova, Mutagenicity studies with nitrofurans: I. Mutagenicity of nitrofurylacrylic acid for mammals, Mutation Res. 68 (1979) 367-380.
35. [35] K. Hansson, Caffeine enhancement of chromosomal aberrations induced by thiotepa in bone marrow cells of mice, Hereditas 89 (1978) 129-131.
36. [36] H.W. Renner, M. Knoll, Antimutagenic effects on male germ cells of mice, Mutation Res. 140 (1984) 127-129.
37. [37] R. Vogel, H. Spielmann, Beneficial effects of ascorbic acid on preimplantation mouse embryos after exposure to cyclophosphamide in vivo, Teratogen. Carcinogen. Mutagen. 9 (1989) 51-59.
38. [38] J. Gandy, H.K. Bates, L.A. Conder, R.D. Harbison, Effects of reproductive tract glutathione enhancement and depletion on ethyl methanesulfonate-induced dominant lethal mutations in Sprague-Dawley rats, Teratogen. Carcinogen. Mutagen. 12 (1992) 61-70.
39. [39] S. De Flora, A. Izzotti, C. Bennicelli, Mechanisms of antimutagenesis and anticarcinogenesis: role in primary prevention, in: G. Bronzetti, H. Hayatsu, S. De Flora, M.D. Waters, D.M. Shankel (Eds.), Antimutagenesis and Anticarcinogenesis Mechanisms III, Plenum, New York, 1993.
40. [40] C.S. Yang, J.F. Brady, J.-Y. Hong, Dietary effects on cytochromes P450, xenobiotic metabolism and toxicity, FASEB J. 6 (1992) 737-744.
41. [41] M.D. Waters, H.F. Stack, M.A. Jackson, H.E. Brockman, S. De Flora, Activity profiles of antimutagens: in vitro and in vivo data, Mutation Res. 350 (1996) 109-129.
42. [42] T. Morita, N. Asano, T. Awogi, Y.F. Sasaki, S. Sato, H. Shimada, S. Sutou, T. Suzuki, A. Wakata, T. Sofuni, M. Hayashi, Evaluation of the rodent micronucleus assay in the screening of IARC carcinogens (Group 1, 2A and 2B). The summary report of the 6th collaborative study by CSGMT/JEMS-MMS, Mutation Res. 389 (1997) 3-122.
43. [43] K. Iwakura, H. Tamura, A. Matsumoto, S. Aimi, S. Ogura, K. Kakimoto, T. Matsumoto, M. Hayashi, The micronucleus assay with peripheral blood reticulocytes by acridine orange supravital staining with 1-β-D-arabinofuranosylcytosine, Mutation Res. 278 (1992) 131-137.
44. [44] F. Marchetti, X. Lowe, D.H. Morre II, J. Bishop, A.J. Wyrobek, Paternally inherited chromosomal structural aberrations detected in mouse first-cleavage zygote metaphases by multicolor fluorescence in situ hybridization painting, Chromosome Res. 4 (1996) 604-613.
45. [45] A.J. Wyrobek, I.-D. Adler, Detection of aneuploidy in human and rodent sperm using FISH and applications of sperm assays of genetic damage in heritable risk evaluation, Mutat. Res. 352 (1996) 173-179.